Atom Investors’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Atom Investors's PRAX Position: Q3 2026 in Review
Atom Investors reduced its Praxis Precision Medicines (PRAX) stake by 33% in Q3 2026, selling an estimated $855K and leaving 5,274 shares worth $1.54M. The position accounts for 0.09% of the portfolio, ranked #254.
Atom Investors first reported a position in PRAX in Q4 2022 and has held it in 9 quarters since. The position peaked at $6.83M in Q1 2026. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Atom Investors held 5,274 shares of Praxis Precision Medicines worth $1.54M as of Q3 2026.
- Atom Investors sold 2,585 Praxis Precision Medicines shares in Q3 2026, an estimated $855K.
- Praxis Precision Medicines made up 0.09% of Atom Investors's portfolio in Q3 2026, its #254 holding.
- Atom Investors first reported a position in Praxis Precision Medicines in Q4 2022 and has held it in 9 quarters since.
- Atom Investors's Praxis Precision Medicines position peaked at $6.83M in Q1 2026.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Atom Investors's 13F filing for Q3 2026, filed 16 Nov 2026.